Abstract
Background: In the current pharmaceutical industry, overcoming drug insolubility is a daunting formulation challenge. The most active drugs (with receptor affinity and specificity and low toxicity) are not necessarily the most druggable, lacking high solubility, stability, permeability or absorption. Since insoluble drug particles show poor bioavailability, one of the solutions to this problem is to aid dissolution rate (kinetic) and solubility (thermodynamic) by nanosizing the drug. Thus, during the past few decades, several strategies based on nanotechnology have been adopted to overcome these problems, which increase production costs and require administration of large doses resulting in higher cost/dose ratios. This review discusses techniques to improve bioavailability and solubility through nanosuspensions, nanoparticles (NPs) as well as using various nanocarriers.
Methods: Bibliographic databases were screened for peer-reviewed research literature of recent origin. The papers were selected based on the relevance to nanotechnological methods for improving drug solubility. Results: Synthesis of metal-based drug encapsulant or a drug conveyor constituting a metallo- drug can affect the drug release potential and the rate of drug release. Carrier-free nanocrystal colloidal delivery systems are found to efficiently solubilize drugs. Furthermore, solid dispersions which are comprised of two components where a drug crystal (diameter D 50% < 20 μm) along with a carrier/disintegrant have been successfully employed. In the area of self-emulsifying hydrophilic and hydrophobic drugs, micelles, liposomes, selfdispersing tablets and emulsions as well as solid lipid NPs are good candidates for efficiently transporting drugs. In addition, drug complexes with cyclodextrins, calixarenes, cucurbiturils and dendrimers have also led to better solubility and bioavailability. Conclusion: These approaches present significant improvements to the solubility and bioavailability of existing drugs and future discoveries.Keywords: Poorly water soluble, bioavailability, nanocrystals, solid suspensions, self-emulsifying drugs, inorganic carriers, soluble complexes.
Graphical Abstract
Current Nanomedicine
Title:Nanotechnological Strategies to Improve Water Solubility of Commercially Available Drugs
Volume: 7 Issue: 2
Author(s): Desiree Nedra Karunaratne*, Isuru R. Ariyarathna, Dhanushi Welideniya, Asitha Siriwardhana, Dinara Gunasekera and Veranja Karunaratne
Affiliation:
- Department of Chemistry, University of Peradeniya, Peradeniya,Sri Lanka
Keywords: Poorly water soluble, bioavailability, nanocrystals, solid suspensions, self-emulsifying drugs, inorganic carriers, soluble complexes.
Abstract: Background: In the current pharmaceutical industry, overcoming drug insolubility is a daunting formulation challenge. The most active drugs (with receptor affinity and specificity and low toxicity) are not necessarily the most druggable, lacking high solubility, stability, permeability or absorption. Since insoluble drug particles show poor bioavailability, one of the solutions to this problem is to aid dissolution rate (kinetic) and solubility (thermodynamic) by nanosizing the drug. Thus, during the past few decades, several strategies based on nanotechnology have been adopted to overcome these problems, which increase production costs and require administration of large doses resulting in higher cost/dose ratios. This review discusses techniques to improve bioavailability and solubility through nanosuspensions, nanoparticles (NPs) as well as using various nanocarriers.
Methods: Bibliographic databases were screened for peer-reviewed research literature of recent origin. The papers were selected based on the relevance to nanotechnological methods for improving drug solubility. Results: Synthesis of metal-based drug encapsulant or a drug conveyor constituting a metallo- drug can affect the drug release potential and the rate of drug release. Carrier-free nanocrystal colloidal delivery systems are found to efficiently solubilize drugs. Furthermore, solid dispersions which are comprised of two components where a drug crystal (diameter D 50% < 20 μm) along with a carrier/disintegrant have been successfully employed. In the area of self-emulsifying hydrophilic and hydrophobic drugs, micelles, liposomes, selfdispersing tablets and emulsions as well as solid lipid NPs are good candidates for efficiently transporting drugs. In addition, drug complexes with cyclodextrins, calixarenes, cucurbiturils and dendrimers have also led to better solubility and bioavailability. Conclusion: These approaches present significant improvements to the solubility and bioavailability of existing drugs and future discoveries.Export Options
About this article
Cite this article as:
Karunaratne Nedra Desiree*, Ariyarathna R. Isuru, Welideniya Dhanushi, Siriwardhana Asitha, Gunasekera Dinara and Karunaratne Veranja, Nanotechnological Strategies to Improve Water Solubility of Commercially Available Drugs, Current Nanomedicine 2017; 7 (2) . https://dx.doi.org/10.2174/2468187307666161227171349
DOI https://dx.doi.org/10.2174/2468187307666161227171349 |
Print ISSN 2468-1873 |
Publisher Name Bentham Science Publisher |
Online ISSN 2468-1881 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Pharmacological Pathways of GnRH Mediating the Inhibition of Mammary Tumours: Implications in Humans and Domestic Animals
Current Medicinal Chemistry Regulating miRNA by Natural Agents as a New Strategy for Cancer Treatment
Current Drug Targets Current Insights into the Role of HIF-1 in Cutaneous Wound Healing
Current Molecular Medicine Impaired Autophagy Mediates Resistance to Low-Dose Metronomic Cyclophosphamide Chemotherapy
Clinical Cancer Drugs 2-Arylbenzothiazole as a Privileged Scaffold in Drug Discovery
Current Medicinal Chemistry Molecular Imaging Kits for Hexosamine Biosynthetic Pathway in Oncology
Current Medicinal Chemistry Majra Honey Abrogated the Normal and Cancer Cells Proliferation Inhibition by Juniperus procera Extract and Extract/Honey Generated AgNPs
Anti-Cancer Agents in Medicinal Chemistry QSAR and 3D-QSAR Models in the Field of Tubulin Inhibitors as Anticancer Agents
Current Topics in Medicinal Chemistry Editorial
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Prospects of Bacteriotherapy with Nanotechnology in Nanoparticledrug Conjugation Approach for Cancer Therapy
Current Medicinal Chemistry Hedgehog Signaling and Urological Cancers
Current Drug Targets ADAM9 as a Potential Target Molecule in Cancer
Current Pharmaceutical Design Estrogen, Immunity & Autoimmune Disease
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Human-Derived Organ-on-a-Chip for Personalized Drug Development
Current Pharmaceutical Design Sporadic Porphyria in a Patient with Stage II Melanoma Treated with Interferon α
Current Drug Safety Role and Pharmacogenomics of TNF-α in Asthma
Mini-Reviews in Medicinal Chemistry ThermoTRP Channels in Nociceptors: Taking a Lead from Capsaicin Receptor TRPV1
Current Neuropharmacology Anticancer Properties of Flavonoids: Roles in Various Stages of Carcinogenesis
Cardiovascular & Hematological Agents in Medicinal Chemistry A Review: Hair Health, Concerns of Shampoo Ingredients and Scalp Nourishing Treatments
Current Pharmaceutical Biotechnology Stem Cell and Gene Therapeutic Strategies for the Treatment of Multiple Sclerosis
Current Molecular Medicine